Correlation Between Dominari Holdings and GT Biopharma

Can any of the company-specific risk be diversified away by investing in both Dominari Holdings and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dominari Holdings and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dominari Holdings and GT Biopharma, you can compare the effects of market volatilities on Dominari Holdings and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dominari Holdings with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dominari Holdings and GT Biopharma.

Diversification Opportunities for Dominari Holdings and GT Biopharma

-0.47

Correlation Coefficient

Dominari Holdings  GT Biopharma

Very good diversification

The 3 months correlation between Dominari and GTBP is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Dominari Holdings and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Dominari Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dominari Holdings are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Dominari Holdings i.e., Dominari Holdings and GT Biopharma go up and down completely randomly.

Pair Corralation between Dominari Holdings and GT Biopharma

Given the investment horizon of 90 days Dominari Holdings is expected to generate 5.36 times more return on investment than GT Biopharma. However, Dominari Holdings is 5.36 times more volatile than GT Biopharma. It trades about 0.35 of its potential returns per unit of risk. GT Biopharma is currently generating about 0.13 per unit of risk. If you would invest  192.00  in Dominari Holdings on November 28, 2024 and sell it today you would earn a total of  730.00  from holding Dominari Holdings or generate 380.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Dominari Holdings  vs.  GT Biopharma

Dominari Holdings

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Dominari Holdings are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak primary indicators, Dominari Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.

GT Biopharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in GT Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, GT Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dominari Holdings and GT Biopharma

The main advantage of trading using opposite Dominari Holdings and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dominari Holdings position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.

The idea behind Dominari Holdings and GT Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.